In addition, they revealed that knockdown of OGT in RCC cells could downregulate the epidermal growth factor receptor (EGFR) and PI3K/AKT pathways, thereby inhibiting the migration, invasion, and vascularization of RCC cells. The gene discussed is PIK3CA; the disease is renal cell carcinoma.